Cargando…
Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury due to inhibition of NOX2-mediated calcium homeostasis dysregulation in mice
BACKGROUND: The incidence of ischemic cerebrovascular disease is increasing in recent years and has been one of the leading causes of neurological dysfunction and death. Ginsenoside Rg1 has been found to protect against neuronal damage in many neurodegenerative diseases. However, the effect and mech...
Autores principales: | Han, Yuli, Li, Xuewang, Yang, Liu, Zhang, Duoduo, Li, Lan, Dong, Xianan, Li, Yan, Qun, Sen, Li, Weizu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270650/ https://www.ncbi.nlm.nih.gov/pubmed/35818419 http://dx.doi.org/10.1016/j.jgr.2021.08.001 |
Ejemplares similares
-
Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice
por: Li, Yan, et al.
Publicado: (2021) -
Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice
por: Dong, Xianan, et al.
Publicado: (2023) -
Ginsenoside Rg1 alleviates lipopolysaccharide-induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells
por: Zhang, Yaodong, et al.
Publicado: (2021) -
Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice
por: Ji, Pengmin, et al.
Publicado: (2023) -
Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice
por: Zhang, Han, et al.
Publicado: (2021)